Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.01. | Treace Medical Concepts reports Q4 preliminary revenue of $68.4M - $68.8M | 1 | Seeking Alpha | ||
13.01. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
31.12.24 | Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital | 4 | MarketBeat | ||
18.12.24 | Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) | 2 | Benzinga.com | ||
16.12.24 | Treace Medical Concepts, Inc.: Treace Announces First Surgical Cases Utilizing the SpeedPlate MicroQuad Implant | 1 | GlobeNewswire (USA) | ||
02.12.24 | Treace Medical Concepts, Inc.: Treace Appoints Guy Guglielmino as Chief Commercial Officer | 97 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
06.11.24 | Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue | 2 | Investing.com | ||
06.11.24 | Quartalsbericht: Treace Medical Concepts verzeichnet 11% Umsatzsteigerung im dritten Quartal | 1 | Investing.com Deutsch | ||
05.11.24 | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Third Quarter 2024 Financial Results | 100 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
05.11.24 | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
05.11.24 | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
04.11.24 | Earnings Preview For Treace Medical Concepts | 2 | Benzinga.com | ||
22.10.24 | Treace Medical Concepts, Inc.: Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 | 2 | GlobeNewswire (USA) | ||
15.10.24 | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
14.10.24 | Treace Medical Concepts, Inc.: Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology | 1 | GlobeNewswire (USA) | ||
18.09.24 | Treace Medical Concepts (TMCI) Slid on Reduced Guidance | 2 | Insider Monkey | ||
17.09.24 | Treace Medical Concepts CEO buys $265k worth of company stock | 2 | Investing.com | ||
11.09.24 | Treace Medical Concepts, Inc.: Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024 | 113 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
22.08.24 | Treace Medical Concepts, Inc.: Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
07.08.24 | Earnings call: Treace Medical sees steady growth and plans new products | 2 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BRIGHTSPRING HEALTH SERVICES | 20,890 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 54,18 | +0,74 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
ATRICURE | 39,630 | 0,00 % | AtriCure (NASDAQ:ATRC) Hits New 52-Week High - Should You Buy? | ||
GERRESHEIMER | 66,20 | -1,27 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
FRESENIUS | 36,340 | +0,36 % | DAX-Check LIVE: Fresenius, Hypoport, Kontron, Lanxess, Nemetschek, Nordex, Porsche AG, RWE, SAP & Co | Der DAX hat gestern die nächste Tausendermarke übersprungen. Erstmalig überwand er 21.000 Punkte. Am Ende des Tages ging er knapp darunter aus dem Handel. Das Tagesplus betrug 0,42 Prozent. Worauf es... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 69,72 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
CARL ZEISS MEDITEC | 49,000 | +0,41 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
GENEDX | 74,33 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 44,700 | +0,81 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
RXSIGHT | 30,920 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
PROGYNY | 21,470 | 0,00 % | Progyny beruft Gesundheitsexpertin Debra Morris in den Vorstand | ||
ALIGNMENT HEALTHCARE | 14,555 | 0,00 % | Alignment Healthcare is latest to sue Medicare over Star Ratings | ||
NANO-X IMAGING | 8,365 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
HELIUS MEDICAL | 1,010 | 0,00 % | Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target | --128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program... ► Artikel lesen | |
CASTLE BIOSCIENCES | 26,680 | 0,00 % | Castle Biosciences CEO Derek Maetzold verkauft Aktien im Wert von 71.902 US-Dollar |